2-nitro-4-carboxyphenyl-n,n-diphenylcarbamate has been researched along with Pulmonary Edema in 1 studies
2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate: inhibits phospholipase C and serine esterases; structure in first source
Pulmonary Edema: Excessive accumulation of extravascular fluid in the lung, an indication of a serious underlying disease or disorder. Pulmonary edema prevents efficient PULMONARY GAS EXCHANGE in the PULMONARY ALVEOLI, and can be life-threatening.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Voelkel, NF | 1 |
| Czartolomna, J | 1 |
| Simpson, J | 1 |
| Murphy, RC | 1 |
1 other study available for 2-nitro-4-carboxyphenyl-n,n-diphenylcarbamate and Pulmonary Edema
| Article | Year |
|---|---|
FMLP causes eicosanoid-dependent vasoconstriction and edema in lungs from endotoxin-primed rats.
Topics: Alkaloids; Androstadienes; Animals; Carbamates; Dose-Response Relationship, Drug; Eicosanoids; Endot | 1992 |